17762 | $CMPI On Alert! Checkmate Pharmaceuticals to | jmtimz | 06/08/2021 8:33:06 AM |
19587 | $CBDD A key driver of the Company's year-to-date | Lets Roll | 12/21/2021 10:01:59 AM |
1113 | SPHS | budfoxfun | 11/12/2015 8:05:13 AM |
1112 | DOLV | budfoxfun | 11/12/2015 8:05:05 AM |
1111 | SMPR | budfoxfun | 11/12/2015 8:04:57 AM |
1110 | PMCB | budfoxfun | 11/12/2015 8:04:47 AM |
1109 | ELTP | budfoxfun | 11/12/2015 8:04:37 AM |
1108 | VNTH | budfoxfun | 11/12/2015 8:04:28 AM |
1107 | DRAM | budfoxfun | 11/12/2015 8:04:17 AM |
1106 | SMPR | budfoxfun | 11/12/2015 8:04:08 AM |
1105 | NWAV | budfoxfun | 11/12/2015 8:03:50 AM |
1104 | FBEC | budfoxfun | 11/12/2015 8:03:40 AM |
1103 | ICNB | budfoxfun | 11/12/2015 8:03:29 AM |
1102 | IGEX | budfoxfun | 11/12/2015 8:03:23 AM |
1101 | MPGS | budfoxfun | 11/12/2015 8:03:15 AM |
1100 | FB | budfoxfun | 11/12/2015 8:03:00 AM |
1099 | GNTP | budfoxfun | 11/12/2015 8:02:52 AM |
1098 | GEQU | budfoxfun | 11/12/2015 8:02:38 AM |
1097 | ILST | budfoxfun | 11/12/2015 8:02:31 AM |
1096 | THCZ | budfoxfun | 11/12/2015 8:02:20 AM |
1095 | EVRM | budfoxfun | 11/12/2015 8:02:14 AM |
1094 | MSOA | budfoxfun | 11/12/2015 8:02:04 AM |
1093 | ONE | budfoxfun | 11/12/2015 8:01:56 AM |
1092 | FLSR | budfoxfun | 11/12/2015 8:01:48 AM |
1091 | UMAX | budfoxfun | 11/12/2015 8:01:38 AM |
1090 | TRTC | budfoxfun | 11/12/2015 8:01:30 AM |
1089 | AVXL | budfoxfun | 11/12/2015 8:01:17 AM |
1088 | BRWC | budfoxfun | 11/12/2015 8:01:01 AM |
1087 | AMDA | budfoxfun | 11/12/2015 8:00:49 AM |
1086 | UBIQ | budfoxfun | 11/12/2015 8:00:41 AM |
1085 | PUGE | budfoxfun | 11/12/2015 8:00:32 AM |
1084 | PNOW | budfoxfun | 11/12/2015 8:00:24 AM |
1083 | ENIP | budfoxfun | 11/12/2015 8:00:09 AM |
1082 | TDEY | budfoxfun | 11/12/2015 7:59:28 AM |
1081 | AAPL | budfoxfun | 11/12/2015 7:59:19 AM |
1080 | AMZN | budfoxfun | 11/12/2015 7:59:13 AM |
1079 | GOOGL | budfoxfun | 11/12/2015 7:59:05 AM |
1078 | NFLX | budfoxfun | 11/12/2015 7:59:01 AM |
1077 | GLD | budfoxfun | 11/12/2015 7:58:55 AM |
1076 | IBM | budfoxfun | 11/12/2015 7:58:50 AM |
1075 | RFMK | budfoxfun | 11/12/2015 7:58:43 AM |
1074 | EPAZ | budfoxfun | 11/12/2015 7:58:34 AM |
1073 | ACLP | budfoxfun | 11/12/2015 7:58:27 AM |
1072 | TWTR | budfoxfun | 11/12/2015 7:58:17 AM |
1071 | FB | budfoxfun | 11/12/2015 7:58:06 AM |
1070 | SPY | budfoxfun | 11/12/2015 7:57:56 AM |
1069 | $PNOW Oveedia Books First Reservation! | budfoxfun | 11/11/2015 3:57:49 PM |
1068 | $AMDA .18 over 16 million in volume heading into | budfoxfun | 11/11/2015 3:57:31 PM |
1067 | $IGEX almost 50 million on the bid now in power | budfoxfun | 11/11/2015 3:35:38 PM |
1066 | AMDA markets a complementary line of non-silicon | cherrob | 11/11/2015 3:16:31 PM |
1065 | Budfoxhub what do you think about $EVSV? Curious | Paul Robinson | 11/11/2015 3:14:38 PM |
1064 | $DRAM NHOD 1.38s hitting now up 5% EOD run | Mr.wong | 11/11/2015 3:10:11 PM |
Recent Articles
- Dogecoin's Market Struggles Amid ETF Launch Challenges
- Understanding Tolebrutinib's Regulatory Journey in MS Treatment
- Exploring Corbion's Recent Share Buyback Developments
- Ipsen Launches Phase III for Groundbreaking IPN10200 in Aesthetics
- Idorsia Expands Global Presence with QUVIVIQ Launch in China
- Efficacy of Roche's Giredestrant in Advanced Breast Cancer
- Prosafe SE Reports Strong Fleet Performance and Outlook
- IPC Announces Strategic Move to Strengthen Bond Presence
- IPC Plans to Hold Fixed Income Investor Meetings to Refinance Bonds
- Sanofi's Tolebrutinib Update: FDA Review Extended for MS Treatment
- International Petroleum Corporation Plans New Bond Issuance
- Razor Labs and Process Automation Join Forces for AI Advancement
- Apple's iPhone 17 Demand Booms as Price Target Reaches New Heights
- Elon Musk and Trump Meet: Implications for Tesla and SpaceX
- Revolutionizing Travel Payments with One Source Orchestration
- Razor Labs and Process Automation Team Up for AI in Mining
- Innovative Consortium Targets Climate-Resilient Food Production
- IP Excellera's New Office Makes Strategic Mark in Abu Dhabi
- Sanofi and Regeneron: Advancements in CSU Treatment with Dupixent
- Sanofi and Regeneron’s Dupixent Receives Positive CHMP Opinion
- VT Markets Celebrates Second Year Partnership with Newcastle
- Regeneron and Sanofi Achieve Milestone with Dupixent's EU Progress
- Exciting Developments: FDA Approves LBL-047 for Autoimmune Disease
- Discovering Anhui: A Blend of Innovation and Heritage
- Bolivia's Inflation Sparks Adoption of USDT by Major Auto Brands
- Revolutionizing GRC: Discover Hyperproof AI for Growth
- Revolutionizing Fintech: The New Age of Payments and AI
- Recent Developments in CEA Industries and Its Road Ahead
- Reed Hastings Supports Trump's H-1B Proposal: Key Insights
- Concerns Over Trump's $350 Billion Investment Proposal
- Quantum Computing Inc. Secures $500 Million Through Private Placement
- SEMI Responds to Recent U.S. H1-B Visa Policy Changes
- Shiba Inu Developer Reacts to $4 Million Security Breach
- Quantum Computing Inc. Secures $500M Funding to Advance Growth
- Blue Origin Achieves Milestone Launch as Bezos and Musk React
- Market Analysis: Bitcoin and Ethereum Struggle Amid Fear
- Tronox Holdings Investors Urged to Act Before Critical Deadline
- Exploring the Global Impact of Dehua International Porcelain Culture
- Bybit Introduces ASTER Listing and Rewards Campaign
- AusperBio Secures $63 Million to Propel Hepatitis B Therapies
- Eye Level Math Olympiad 2025: Global Registration Now Open
- Important Legal Steps for LifeMD, Inc. Investors to Consider
- Revolutionizing Weight Loss: ASC47 and Semaglutide Study Results
- Faraday Future Invests $41 Million in Qualigen for Growth
- Faraday Future's $41 Million Investment to Boost Crypto Ambitions
- WuXi AppTec Announces Significant Dividend Distribution Plan
- Your Guide to Expanding into the Lucrative Asia-Pacific Market
- 3 Ways to Prepare for a Life Insurance Medical Exam In 2025
- Investors of RCI Hospitality Holdings Urged to Act Quickly
- Important Class Action for Lantheus Holdings Investors to Note